EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia
H. Matsuo(Kyoto University), Souichi Adachi(Kyoto University), N. Shiba(Gunma University), Daisuke Tomizawa(National Center For Child Health and Development), Takashi Taga(Erasmus MC), Y Hayashi(Saitama Children's Medical Center), Yuka Yamashita(Kanazawa Medical University), Akira Shimada(Tohoku University), Akio Tawa(Erasmus MC), Mikio Kajihara(Kitasato University), Kentaro Ohki(National Center For Child Health and Development), Mayu Tokumasu(Kyoto University), Akitoshi Kinoshita(St. Marianna University School of Medicine), Hiroshi Itoh(Yamaguchi University), Shiro Tanaka(University of Tokyo Health Sciences), Tomohiko Taki(Kyorin University), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Kenji Kodama(Osaka Ekisaikai Hospital), Hideki Nakayama(National Hospital Organization Kyushu Cancer Center), J Fujimoto(National Center For Child Health and Development), Keizo Horibe(National Hospital Organization)
Cited by 42
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383